Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$26.5M Buy
188,900
+162,118
+605% +$21.2M 0.02% 782
2014
Q2
$3.17M Sell
26,782
-32,000
-54% -$3.7M ﹤0.01% 2409
2014
Q1
$7.25M Sell
58,782
-58,218
-50% -$7.06M 0.01% 1515
2013
Q4
$13.3M Buy
117,000
+15,900
+16% +$1.81M 0.01% 1064
2013
Q3
$11.3M Sell
101,100
-34,400
-25% -$3.73M 0.01% 1036
2013
Q2
$13.4M Buy
+135,500
New +$14.1M 0.02% 874

Other funds holding AMGN

UBS's AMGN Position: Q3 2014 in Review

UBS increased its Amgen (AMGN) stake by 186% in Q3 2014, buying an estimated $387M and bringing the position to 4,556,244 shares worth $640M. The position accounts for 0.47% of the portfolio, ranked #25.

UBS first reported a position in AMGN in Q2 2013 and has held it in 6 quarters since. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • UBS held 4,556,244 shares of Amgen worth $640M as of Q3 2014.
  • UBS bought 2,962,203 Amgen shares in Q3 2014, an estimated $387M.
  • Amgen made up 0.47% of UBS's portfolio in Q3 2014, its #25 holding.
  • UBS first reported a position in Amgen in Q2 2013 and has held it in 6 quarters since.
  • 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.